Renaissance Technologies - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 75 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$11
-100.0%
104,800
-97.2%
0.00%
-100.0%
Q3 2022$572,000
-21.8%
3,762,374
+353.0%
0.00%0.0%
Q2 2022$731,000
-50.0%
830,612
-29.5%
0.00%
-50.0%
Q1 2022$1,461,000
+352.3%
1,178,489
+1048.2%
0.00%
Q2 2021$323,000
-80.1%
102,641
-87.7%
0.00%
-100.0%
Q4 2020$1,620,000
+1783.7%
834,999
+573.4%
0.00%
Q3 2020$86,000
+1333.3%
124,000
+937.7%
0.00%
Q2 2020$6,00011,9500.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders